Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trond P Leren

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 2002
[How common is familial hypercholesterolemia?]Trond P Leren
Atherosclerosis|September 16, 2014
Sorting an LDL receptor with bound PCSK9 to intracellular degradationTrond P Leren
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 31, 2010
Mutations in APOA-I and ABCA1 in Norwegians with low levels of HDL cholesterolKnut Erik Berge, Trond P Leren
Cardiology in the Young|December 4, 2008
Familial atrial septal defect in the oval fossa with progressive prolongation of the atrioventricular conduction caused by mutations in the NKX2.5 genePer G Bjørnstad, Trond P Leren
Plos One|March 3, 2011
Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treatedTrond P Leren, Knut Erik Berge
Atherosclerosis|March 19, 2021
Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020Trond P Leren, Martin Prøven Bogsrud
Current Opinion in Lipidology|August 9, 2022
Cascade screening for familial hypercholesterolemia should be organized at a national levelTrond P Leren, Martin Prøven Bogsrud
Journal of Clinical Lipidology|September 4, 2021
The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in NorwayTrond P Leren, Martin Prøven Bogsrud
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 20, 2008
Identification of mutations in the apolipoprotein B-100 gene and in the PCSK9 gene as the cause of hypocholesterolemiaTrond P Leren, Knut Erik Berge
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 29, 2004
[Gitelman's syndrome--a differential diagnosis in hypokalemia]Anders Hovland, Eyvind Bjørbaek, Trond P Leren
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 2002
[How common is familial hypercholesterolemia?]Trond P Leren
Atherosclerosis|September 16, 2014
Sorting an LDL receptor with bound PCSK9 to intracellular degradationTrond P Leren
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 31, 2010
Mutations in APOA-I and ABCA1 in Norwegians with low levels of HDL cholesterolKnut Erik Berge, Trond P Leren
Cardiology in the Young|December 4, 2008
Familial atrial septal defect in the oval fossa with progressive prolongation of the atrioventricular conduction caused by mutations in the NKX2.5 genePer G Bjørnstad, Trond P Leren
Plos One|March 3, 2011
Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treatedTrond P Leren, Knut Erik Berge
Atherosclerosis|March 19, 2021
Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020Trond P Leren, Martin Prøven Bogsrud
Current Opinion in Lipidology|August 9, 2022
Cascade screening for familial hypercholesterolemia should be organized at a national levelTrond P Leren, Martin Prøven Bogsrud
Journal of Clinical Lipidology|September 4, 2021
The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in NorwayTrond P Leren, Martin Prøven Bogsrud
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 20, 2008
Identification of mutations in the apolipoprotein B-100 gene and in the PCSK9 gene as the cause of hypocholesterolemiaTrond P Leren, Knut Erik Berge
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 29, 2004
[Gitelman's syndrome--a differential diagnosis in hypokalemia]Anders Hovland, Eyvind Bjørbaek, Trond P Leren
Pageof 12